Leukoplakia
Information
- Disease name
- Leukoplakia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04267419 | Completed | Malondialdehyde and Nitrous Oxide as Salivary Biomarkers for Different Oral Lesions | February 18, 2019 | December 15, 2019 | |
NCT00179361 | Completed | Natural History of Oro-pharyngeal Cancer Precursors | November 2004 | July 2014 | |
NCT00571974 | Completed | Phase 1/Phase 2 | Treatment of Oral Premalignant Lesions With 5-ALA PDT | January 2007 | January 2012 |
NCT01497951 | Completed | Phase 3 | Photodynamic Therapy for Oral Precursor Lesions | May 2011 | January 2017 |
NCT00001698 | Completed | Phase 2 | Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR | June 1998 | June 2004 |
NCT05323292 | Enrolling by invitation | Vitamin A Status in Patients With Vocal Fold Leukoplakia | June 29, 2022 | December 31, 2026 | |
NCT06325514 | Not yet recruiting | Artificial Intelligence Based Program to Classify Oral Cavity Findings Based on Clinical Image Analysis | April 1, 2024 | September 1, 2024 | |
NCT03603223 | Recruiting | Phase 2 | Pembrolizumab in Treating Participants With Leukoplakia | May 3, 2019 | June 1, 2025 |
NCT05536037 | Terminated | Phase 1 | Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions | May 4, 2022 | March 16, 2024 |
NCT03990636 | Unknown status | Phase 2 | Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial | October 17, 2019 | December 15, 2021 |
NCT02737176 | Unknown status | N/A | Tobacco Cessation Intervention Study for Oral Diseases | April 2016 | December 2018 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D007971